Pharmaceutical Executive
Pharmaceutical professionals, teams, and organizations can succeed at an elite level by tackling the tough mental challenges of Navy SEAL training.
Training to become a United States Navy SEAL (SEa, Land, and Air) is considered among the most intensive preparation in the world. The average successful Navy SEAL candidate spends over a year in a series of formal training environments, including a rigorous Boot Camp; Basic Underwater Demolition; Basic Parachute Training; and Advanced Specialty Training.
While most people focus on the physical challenges of SEAL training, few appreciate the arduous mental preparation that helps SEALs win a mission even before they conduct it. In his recent book, The Way of the Seal: Think Like an Elite Warrior to Lead and Succeed, former SEAL Mark Devine reveals many SEAL conceptual frameworks that can be used for not only military battles but also brand battles.
Photo: Thinkstock
Devine believes that "to win at anything, we must first control our minds." Pharmaceutical professionals, teams, and organizations can apply many of these conceptual practices to enhance their mental toughness and establish a winning attitude. Here are some of the most relevant SEAL principles to help pharmaceutical professionals succeed at an elite level.
Pharma professionals can leverage front-sight focus to complete prioritized projects, streamline their commitments, and start new initiatives without getting derailed. The FITS Process can help these professionals identify the three to five "highest value targets" or the essential action steps for winning against competitors.
Very few people have the ability, desire, or opportunity to become a Navy SEAL. However, pharma professionals can apply these cutting-edge approaches to learn the mental fortitude, leadership skills, and winning mentality of the world's most elite warriors.
Stan Bernard, MD, MBA, is President of Bernard Associates LLC. He can be reached at SBernardMD@BernardAssociatesLLC.com. Dr. Bernard is a member of Pharm Exec's Editorial Advisory Board.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
2 Commerce Drive
Cranbury, NJ 08512